The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Multi-targeting by monotherapeutic antibacterials
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Inactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Carter, A. P., Clemons, W. M., Brodersen, D. E., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Nature · doi:10.1038/35030019 · Cited by 1,615
DNA gyrase: an enzyme that introduces superhelical turns into DNA.
Gellert, M., Mizuuchi, K., O'Dea, M. H., & Nash, H. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3872 · Cited by 1,204
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
rrndb: the Ribosomal RNA Operon Copy Number Database
Klappenbach, J. A. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.181 · Cited by 1,081
Tipper, D. J., & Strominger, J. L. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.4.1133 · Cited by 1,008 · cited 1×
“Penicillin inhibits the crosslinking reaction of muropeptide subunits — undecaprenyl-pyrophosphoryl- N -acetylmuramyl-(pentapeptide)- N -acetylglucosamine (known as Lipid II”
BackgroundSpratt, B. G. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2999 · Cited by 971
Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity
Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T., & Tomizawa, J.-I. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4772 · Cited by 833
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
Sugino, A., Peebles, C. L., Kreuzer, K. N., & Cozzarelli, N. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4767 · Cited by 784
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents
Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., & Brundage, R. P. (1962) · Journal of Medicinal and Pharmaceutical Chemistry · doi:10.1021/jm01240a021 · Cited by 766
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Gellert, M., O'Dea, M. H., Itoh, T., & Tomizawa, J. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.12.4474 · Cited by 727
Scorpio, A., & Zhang, Y. (1996) · Nature Medicine · doi:10.1038/nm0696-662 · Cited by 726
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
Mutation Frequencies and Antibiotic Resistance
Martinez, J. L., & Baquero, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1771-1777.2000 · Cited by 694
Resistance to Antibiotics Mediated by Target Alterations
Spratt, B. G. (1994) · Science · doi:10.1126/science.8153626 · Cited by 674
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Multimodular Penicillin-Binding Proteins: An Enigmatic Family of Orthologs and Paralogs
Goffin, C., & Ghuysen, J.-M. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1079-1093.1998 · Cited by 636
The Structures of Four Macrolide Antibiotics Bound to the Large Ribosomal Subunit
Hansen, J. L., Ippolito, J. A., Ban, N., Nissen, P., Moore, P. B., & Steitz, T. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00570-1 · Cited by 568
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Friedman, L., Alder, J. D., & Silverman, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-06 · Cited by 454
Gemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., & Warren, R. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl017 · Cited by 439
Tu, D., Blaha, G., Moore, P. B., & Steitz, T. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.005 · Cited by 433
Cui, L., Tominaga, E., Neoh, H.-M., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1079-1082.2006 · Cited by 427
Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1127-1134.2005 · Cited by 425
Kinship and Diversification of Bacterial Penicillin-Binding Proteins and β-Lactamases
Massova, I., & Mobashery, S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.1 · Cited by 422
Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
Gillespie, S. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.267-274.2002 · Cited by 412
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Kehrenberg, C., & Schwarz, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1156-1163.2006 · Cited by 398
Zhao, X., & Drlica, K. (2001) · Clinical Infectious Diseases · doi:10.1086/321841 · Cited by 397
Blumberg, P. M., & Strominger, J. L. (1974) · Bacteriological Reviews · doi:10.1128/br.38.3.291-335.1974 · Cited by 381
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378
Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives
Rattan, A., Kalia, A., & Ahmad, N. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980207 · Cited by 355
Wise, E. M., & Park, J. T. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.1.75 · Cited by 347
Kehrenberg, C., Schwarz, S., Jacobsen, L., Hansen, L. H., & Vester, B. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04754.x · Cited by 333
Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding d -Ala- d -Ala
Ge, M., Chen, Z., Russell, H., Onishi, Kohler, J., Silver, L. L., Kerns, R., Fukuzawa, S., Thompson, C., & Kahne, D. (1999) · Science · doi:10.1126/science.284.5413.507 · Cited by 318
Self-citationTransferable vancomycin and teicoplanin resistance in Enterococcus faecium
Leclercq, R., Derlot, E., Weber, M., Duval, J., & Courvalin, P. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.1.10 · Cited by 306
Prystowsky, J., Siddiqui, F., Chosay, J., Shinabarger, D. L., Millichap, J., Peterson, L. R., & Noskin, G. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2154-2156.2001 · Cited by 302
Tigecycline: A Critical Analysis
Stein, G. E., & Craig, W. A. (2006) · Clinical Infectious Diseases · doi:10.1086/505494 · Cited by 298
Hansen, L. H., Mauvais, P., & Douthwaite, S. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01202.x · Cited by 291
Biosynthesis of the Peptidoglycan of Bacterial Cell Walls
Izaki, K., Matsuhashi, M., & Strominger, J. L. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93393-4 · Cited by 290
Denome, S. A., Elf, P. K., Henderson, T. A., Nelson, D. E., & Young, K. D. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.13.3981-3993.1999 · Cited by 288
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.972-978.2003 · Cited by 286 · cited 1×
“, but it is not as effective against many Pseudomonas aeruginosa clinical isolates, a limitation that is due to MexAB-OprM and MexCD-OprJ efflux pump”
BackgroundTait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2118-2125.2000 · Cited by 281
Spratt, B., Bowler, L., Zhang, Q.-Y., Zhou, J., & Smith, J. (1992) · Journal of Molecular Evolution · doi:10.1007/bf00182388 · Cited by 270
Biosynthesis of the peptidoglycan of bacterial cell walls
Anderson, J. S., Meadow, P. M., Haskin, M. A., & Strominger, J. L. (1966) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(66)90056-7 · Cited by 264
The interaction between coumarin drugs and DNA gyrase
Maxwell, A. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01728.x · Cited by 264
Gene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis
Marshall, S. H., Donskey, C. J., Hutton-Thomas, R., Salata, R. A., & Rice, L. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3334-3336.2002 · Cited by 263
Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Dowson, C. G., Coffey, T. J., Kell, C., & Whiley, R. A. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01723.x · Cited by 259
Discovery and development of new antibiotics: the problem of antibiotic resistance
Silver, L. L., & Bostian, K. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.377 · Cited by 253
Self-citationGlycopeptide Antibiotic Resistance Genes in Glycopeptide-Producing Organisms
Marshall, C. G., Lessard, I. A. D., Park, I.-S., & Wright, G. D. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2215 · Cited by 252
Johansen, S. K., Maus, C. E., Plikaytis, B. B., & Douthwaite, S. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.044 · Cited by 244
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli
Sigmund, C. D., Ettayebi, M., & Morgan, E. A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.11.4653 · Cited by 243
Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli
Nilsson, A. I., Berg, O. G., Aspevall, O., Kahlmeter, G., & Andersson, D. I. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2850-2858.2003 · Cited by 241
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
The Antituberculosis Drug Ethionamide Is Activated by a Flavoprotein Monooxygenase
Vannelli, T. A., Dykman, A., & Ortiz de Montellano, P. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110751200 · Cited by 232
Pinho, M. G., Filipe, S. R., de Lencastre, H., & Tomasz, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.22.6525-6531.2001 · Cited by 225
Canu, A., Malbruny, B., Coquemont, M., Davies, T. A., Appelbaum, P. C., & Leclercq, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.125-131.2002 · Cited by 218
Mechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis
Alangaden, G. J., Kreiswirth, B. N., Aouad, A., Khetarpal, M., Igno, F. R., Moghazeh, S. L., Manavathu, E. K., & Lerner, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1295 · Cited by 214
Functional, biophysical, and structural bases for antibacterial activity of tigecycline
Olson, M. W., Ruzin, A., Feyfant, E., Rush, T. S., O'Connell, J., & Bradford, P. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01499-05 · Cited by 207
Prunier, A., Malbruny, B., Laurans, M., Brouard, J., Duhamel, J., & Leclercq, R. (2003) · The Journal of Infectious Diseases · doi:10.1086/374937 · Cited by 199
Kim, D. H., Lees, W. J., Kempsell, K. E., Lane, W. S., Duncan, K., & Walsh, C. T. (1996) · Biochemistry · doi:10.1021/bi952937w · Cited by 192
Curtis, N. A., Orr, D., Ross, G. W., & Boulton, M. G. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.5.533 · Cited by 187
Ketolides lack inducibility properties of MLS(B) resistance phenotype
Bonnefoy, A. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.85 · Cited by 183
Rengarajan, J., Sassetti, C. M., Naroditskaya, V., Sloutsky, A., Bloom, B. R., & Rubin, E. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04120.x · Cited by 174
Getting to the route of Helicobacter pylori treatment
Goddard, A. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.1.1 · Cited by 172
Origin and Evolution of the AmpC β-Lactamases of Citrobacter freundii
Barlow, M., & Hall, B. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1190-1198.2002 · Cited by 169
Wu, S. W., de Lencastre, H., & Tomasz, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.8.2417-2424.2001 · Cited by 167
Structural Insight into the Antibiotic Action of Telithromycin against Resistant Mutants
Berisio, R., Harms, J., Schluenzen, F., Zarivach, R., Hansen, H. A. S., Fucini, P., & Yonath, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.14.4276-4279.2003 · Cited by 165
Mutations in 16S ribosomal RNA disrupt antibiotic-RNA interactions.
De Stasio, E. A., Moazed, D., Noller, H. F., & Dahlberg, A. E. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03494.x · Cited by 164
Design of Novel Antibiotics that Bind to the Ribosomal Acyltransfer Site
Haddad, J., Kotra, L. P., Llano-Sotelo, B., Kim, C., Azucena, E. F., Liu, M., Vakulenko, S. B., Chow, C. S., & Mobashery, S. (2002) · Journal of the American Chemical Society · doi:10.1021/ja011695m · Cited by 164
Bellon, S., Parsons, J. D., Wei, Y., Hayakawa, K., Swenson, L. L., Charifson, P. S., Lippke, J. A., Aldape, R., & Gross, C. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1856-1864.2004 · Cited by 159
Pereyre, S., Guyot, C., Renaudin, H., Charron, A., Bébéar, C., Bébéar, C., Bébéar, C., & Bébéar, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.460-465.2004 · Cited by 144
Gregory, S. T., & Dahĺberg, A. E. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2839 · Cited by 139
Penicillin-binding proteins in bacteria
Georgopapadakou, N. H., & Liu, F. Y. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.18.1.148 · Cited by 139
Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli
Chittum, H. S., & Champney, W. S. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.20.6192-6198.1994 · Cited by 134
Two Active Forms of UDP- N -Acetylglucosamine Enolpyruvyl Transferase in Gram-Positive Bacteria
Du, W., Brown, J. R., Sylvester, D., Huang, J., Chalker, A. F., So, C. Y., Holmes, D. J., Payne, D. J., & Wallis, N. G. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.15.4146-4152.2000 · Cited by 133
Effects of Efflux Transporter Genes on Susceptibility of Escherichia coli to Tigecycline (GAR-936)
Hirata, T., Saito, A., Nishino, K., Tamura, N., & Yamaguchi, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2179-2184.2004 · Cited by 124
Takei, M., Fukuda, H., Kishii, R., & Hosaka, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3544-3547.2001 · Cited by 123
Meier, A., Heifets, L. B., Wallace, R. J., Zhang, Y., Brown, B. A., Sander, P., & Böttger, E. C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.354 · Cited by 117
Glycopeptides: Update on an old successful antibiotic class
Pace, J., & Yang, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.005 · Cited by 107
Screening of natural products for antimicrobial agents
Silver, L. L., & Bostian, K. A. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01964283 · Cited by 104
Self-citationFarrell, D. J., Douthwaite, S. R., Morrissey, I., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1777-1783.2003 · Cited by 101
Prunier, A., Malbruny, B., Tandé, D., Picard, B., & Leclercq, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3054-3056.2002 · Cited by 90
Targeting extracellular pyrophosphates underpins the high selectivity of nisin
Bonev, B. B., Breukink, E. J., Świeżewska, E., KRUIJFF, B. D., & Watts, A. G. (2004) · The FASEB Journal · doi:10.1096/fj.04-2358com · Cited by 85
Pinho, M. G., de LENCASTRE, H., & Tomasz, A. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.4.1074-1079.2000 · Cited by 85
Structure–activity relationships of ketolides vs. macrolides
Douthwaite, S. R. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2001.0070s3011.x · Cited by 84
Iizawa, Y., Nagai, J., Ishikawa, T., Hashiguchi, S., Nαkαo, M., Miyake, A., & Okonogi, K. (2004) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-004-0309-3 · Cited by 84
Structure-based drug design meets the ribosome
Franceschi, F. J., & Duffy, E. M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.026 · Cited by 81
Russell, R. J. M., Murray, J. B., Lentzen, G., Haddad, J., & Mobashery, S. (2003) · Journal of the American Chemical Society · doi:10.1021/ja029736h · Cited by 72
Strahilevitz, J., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1949-1956.2005 · Cited by 67
Ramoplanin: A Lipoglycodepsipeptide Antibiotic
Farver, D., Hedge, D. D., & Lee, S. C. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e397 · Cited by 67
On the nature of antibiotic binding sites in ribosomes
Cundliffe, E. (1987) · Biochimie · doi:10.1016/0300-9084(87)90213-6 · Cited by 63
Fujimoto-Nakamura, M., Ito, H., Oyamada, Y., Nishino, T., & Yamagishi, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3810-3815.2005 · Cited by 63
Penicillin-Binding Protein 1 of Staphylococcus aureus Is Essential for Growth
Wada, A., & Watanabe, H. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.10.2759-2765.1998 · Cited by 58
When will the genomics investment pay off for antibacterial discovery?
Mills, S. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.025 · Cited by 58
In Vitro and In Vivo Antibacterial Activities of CS-023 (RO4908463), a Novel Parenteral Carbapenem
Koga, T., Abe, T., Inoue, H., Takenouchi, T., Kitayama, A., Yoshida, T., Masuda, N., Sugihara, C., Kakuta, M., Nakagawa, M., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3239-3250.2005 · Cited by 52
Use of genomics to select antibacterial targets
Pucci, M. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.004 · Cited by 50
Mining bacterial genomes for antimicrobial targets
Loferer, H. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01815-3 · Cited by 33
Doktor, S. Z., Shortridge, V. D., Beyer, J. M., et al. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00130-5 · Cited by 26
Active site directed inhibitors of replication-specific bacterial DNA polymerases.
Wright, G., Brown, N., Xu, W.-C., Long, Z.-Y., Zhi, C., Gambino, J., Barnes, M., & Butler, M. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.016 · Cited by 25
Crystallizing new approaches for antimicrobial drug discovery
Schmid, M. B. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.024 · Cited by 21
Butler, M., Skow, D., Stephenson, R. O., Lyden, P. T., Lamarr, W., & Foster, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3770-3775.2002 · Cited by 20
Protein synthesis as a target for antibacterial drugs: current status and future opportunities
Chopra, I. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.8.1237 · Cited by 11
Cited by
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., & Young, D. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,422
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Self-citationNatural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Mechanisms of drug combinations: interaction and network perspectives
Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2683 · Cited by 969
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Metadata
- Authors
- Silver, L. L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-01-01
- Volume
- 6
- Issue
- 1
- Pages
- 41-55
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1989889086
- Cited by
- 311
- References
- 109
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.